Skip to main content
. 2018 Oct 2;5(4):81. doi: 10.3390/bioengineering5040081

Table 1.

Zebrafish in cancer modeling.

Benefits Limitations
Translational relevance: similarities between humans and zebrafish Largely conserved development and signaling pathways Function of innate and adaptive immune cells is highly conserved Over 80% of human disease-related genes present Whole-genome duplication (more than one ortholog for some human genes) may interfere with genetic studies
Xenograft models [79,81,84] Can be generated from human, mouse, or zebrafish tumors No rejection due to immature adaptive immune system in larvae Recapitulates parental tumor behaviors including proliferation, survival, invasion, and dissemination Molecular interactions between transplanted human or mouse tumors and zebrafish cells unclear
Genetically engineered zebrafish models (GEZMs) [82,85,86] Easy genetic manipulation—injection into one-cell-stage larvae possible Fast development Comparable histology to human cancers Tumor initiation and progression studies hindered by lack of a functional adaptive immune system in early-stage models
Drug studies Easy, cost-effective, and high scalability Ease of imaging and high-throughput screening with transparent larvae High degree of conservation of metabolic enzymes between human and zebrafish larvae Pharmacokinetic processes still unclear